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Abstract 
Background: The influence of dietary fat upon breast cancer mortality remains largely 
understudied despite extensive investigation into its influence upon breast cancer risk Objective: 
To conduct meta-analyses of studies to clarify the association between dietary fat and breast 
cancer mortality Design: MEDLINE and EMBASE were searched for relevant articles published 
up to March 2012. Risk of all-cause or breast cancer specific death was evaluated by combining 
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multivariable adjusted estimates comparing highest versus lowest categories of intake; and per 
20 gram increase in intake of total and/or saturated fat (g/day) using random-effects meta-
analyses. Results: Fifteen prospective cohort studies investigating total fat and/or saturated fat 
intake (g/day) and breast cancer mortality were included. There was no difference in risk of 
breast cancer specific death (n=6; HR=1.14; 95% CI: 0.86, 1.52; P=0.34) or all cause death (n=4; 
HR=1.73; 95% CI: 0.82, 3.66; P=0.15) for women in the highest versus lowest category of total 
fat intake. Breast cancer specific death (n=4; HR=1.51; 95% CI: 1.09, 2.09; P<0.01) was higher 
for women in the highest versus lowest category of saturated fat intake.Conclusions: These 
meta-analyses have shown that saturated fat intake negatively impacts upon breast cancer 
survival. 
Keywords 
dietary fat; saturated fat; breast cancer survival 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 3 
Introduction 
As the number of breast cancer survivors increases worldwide (Cancer Research UK, 2011), 
there is growing interest in the potential effect of dietary and lifestyle behaviours on overall 
prognosis. This is especially important as a cancer diagnosis is often referred to as a „teachable 
moment‟ when patients are motivated to make changes to their lifestyle and so provision of 
evidence-based guidelines is essential (Demark-Wahnefried et al., 2005). 
The widely postulated association between dietary fat and breast cancer risk was initially based 
upon ecologic and animal studies (Willett, 1998; Greenwald, 1999; Hunter, 1999). Subsequently, 
a randomised controlled trial (Rohan et al., 2008) and multiple observational studies 
investigating the association have been conducted and several meta-analyses have reported 
increased breast cancer risk with increased dietary fat intake (Boyd et al., 1993; Boyd et al., 
2003). In a combined analysis of 12 case-control studies, saturated fat intake was also associated 
with an increased risk of breast cancer, especially in postmenopausal women (Howe et al., 1990). 
Yet in a pooled analysis of cohort studies, no evidence of any association was observed (Hunter 
et al., 1996). The inconsistencies observed may be due to the studies included in the different 
meta-analyses, which span 13 years, or the methodologies used in these studies (Howe, 1994). 
Consequently, the World Cancer Research Fund/American Institute for Cancer Research 
(WCRF/AICR) report on „Food, Nutrition, Physical Activity, and the Prevention of Cancer‟ 
(2007) concluded that there was limited suggestive evidence that total fat increases risk of 
postmenopausal breast cancer, but that for premenopausal breast cancer there was limited 
evidence and no conclusions could be drawn (WCRF/AICR, 2007). 
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The influence of dietary fat on breast cancer mortality also remains unclear as the results of 
several randomised controlled trials are conflicting. In the Women‟s Intervention Nutrition Study 
(WINS), a reduction in breast cancer recurrence was seen in those who had adopted a low-fat 
dietary pattern (15% of energy intake from fat) with decreased intakes of oils and sweets and 
increased fruit consumption, in comparison with those in the control group. Yet there was 
significant weight loss in the intervention group and a higher frequency of mastectomy which 
may have confounded results (Chlebowski et al., 2006). In contrast, in the Women‟s Healthy 
Eating and Living (WHEL) randomised controlled trial, women in the intervention arm who 
consumed 15-20% of energy, 5 vegetable servings, 16 oz vegetable juice, 3 fruit servings and 
30g fibre per day did not have a significantly reduced risk of recurrence (Pierce et al., 2007). 
Although the results obtained are of interest, it is impossible from these studies to firmly 
establish the effect of dietary fat intake on breast cancer mortality as they were designed to 
achieve an overall dietary intervention change which only included a reduction in dietary fat 
intake. 
In the absence of randomised controlled trials of fat and breast cancer recurrence, it is important 
to review other sources of evidence. A substantial number of cohort studies have examined the 
relationship between habitual dietary fat intake and breast cancer survival, yet, to date, the 
evidence provided by these has not been systematically reviewed. Our aim is to conduct a 
systematic review to establish whether an association exists between dietary fat intake and breast 
cancer mortality and, where possible, to quantify the relationship using meta-analysis of 
individual studies to produce a pooled estimate. 
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Methods 
Study selection 
An electronic literature search was conducted in the databases Ovid MEDLINE (US National 
Library of Medicine, Betheseda, MD) and EMBASE (Reed Elsevier PLC, Amsterdam, 
Netherlands) to identify human studies published in the English language up to March 2012 that 
included the following keywords or phrases: (dietary fat(s) or dietary cholesterol or saturated 
dietary fat(s)) and (survivorship or disease-free survival or survival rate or survival) and (breast 
neoplasm(s) or breast tumo(u)r or breast cancer survival or breast cancer or cancer of the breast). 
Four independent reviewers (SFB, PML, JVW, MMC) considered the abstracts of the articles 
retrieved in the initial search to identify potentially relevant studies which examined dietary fat 
and breast cancer mortality. All reviewers agreed on the potential articles and full-texts of these 
were obtained. Reference lists of the considered articles were searched for any further papers 
which may not have been identified in the database searches. Only studies which reported risk 
estimates (hazard ratios, odds ratios and relative risks), and measures of variability (standard 
errors [SEs] or 95% confidence intervals [CIs] from which these could be derived), for all-cause 
and/or breast cancer mortality according to total fat intake and/or saturated fat intake were 
included. 
Data extraction 
Information extracted from each study included geographic region, study design, year of 
publication, sample size, number of cancer cases, dietary assessment method, timing of dietary 
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assessment (relative to diagnosis), duration of follow-up, risk estimates with 95% CIs and 
confounding variables adjusted for in the analysis. 
Statistical analyses 
The original studies reported hazard ratios (HR) for all-cause or breast cancer specific death by 
categories (in fifths, fourths or thirds) of total fat/saturated fat intake. Where possible, results 
were converted to g/day by calculation or by requesting the results in this format from the article 
author. Meta-analyses were conducted to evaluate the risk of all-cause or breast cancer specific 
death in women in the highest compared with the lowest reported categories of total fat intake 
(g/day) and women in the highest compared with the lowest categories of saturated fat (g/day). 
Additionally, the linear increase in risk of breast cancer and all-cause death per percentile 
increase in total fat and saturated fat intake (g/day) was estimated by conducting a regression of 
the HRs in the categories of total and saturated fat intake against the average percentile in each 
category where possible using the methods by Greenland and Longnecker and otherwise using 
variance-weighted least-squares linear regression (Greenland & Longnecker, 1992). This linear 
increase was converted to an estimate for a 20
th
 percentile increase in total fat and/or saturated 
fat intake. Multivariable adjusted hazards ratios, odds ratios and relative risks with 95% CIs from 
individual studies were weighted and combined using an inverse-variance weighted random-
effects model to produce a pooled estimate (DerSimonian & Laird, 1986). Heterogeneity was 
tested with a chi-squared test and measured using the I
2
 statistic (Higgins et al., 2003). Each 
study‟s estimate and 95% CI and SE were presented in a forest plot along with the pooled 
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estimate. Publication bias was assessed from inspection of the funnel plot and by statistical 
analysis using Begg‟s and Egger‟s tests (Sterne & Egger, 2001). 
Subgroup analyses were conducted for: studies which had adjusted for energy intake and for 
those which had not; studies which used FFQs for dietary assessment and those which used diet 
histories/recalls; and finally studies which assessed diet pre-diagnosis and those which assessed 
diet post-diagnosis 
Statistical analyses were conducted with Intercooled STATA version 9.2 (2005; StataCorp, 
College Station, TX). 
Results 
Inclusion 
The electronic literature search identified 82 potentially relevant publications. Of these, 33 
papers were initially excluded as they did not examine dietary fat and breast cancer mortality. Of 
the 49 articles which remained, the following papers were excluded: 5 randomised controlled 
trials (Chlebowski et al., 2006; Pierce et al., 2007; Winters et al., 2004; Stolley et al., 2009; Hoy 
et al., 2009), 1 ecological study (Kesteloot et al., 1994), 18 reviews (Wynder et al., 1986; 
Chlebowski et al., 1992; Wynder et al., 1992; Colditz, 1993; Cohen et al., 1993; Ganz & Schag, 
1993; Nixon, 1996; Stoll, 1996; Wynder et al., 1997; Jatoi & Loprinzi, 1999; Newman et al., 
1999; Rock & Demark-Wahnefried, 2001; Blackburn et al., 2003; Holmes & Kroenke, 2004; 
Blackburn & Wang, 2007; Kellen et al., 2009), 7 editorials/letters/supplements/communications 
(Hebert & Wynder, 1987; Lipmann, 1987; Thiébaut et al., 2006; Kurt & Altundag, 2007; Pierce 
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et al., 2007; Gapstur & Khan, 2007; Nelson, 2008) one study which examined marine fatty acid 
intake (Patterson et al., 2011), one study which presented results as foods and not nutrients 
(Hebert et al., 1998) and one study which did not provide usable estimates for dietary fat and 
breast cancer survival (Holm et al., 1993). 
Fifteen articles examined dietary fat intake (total fat and/or saturated fat (g)) and all-cause and 
breast cancer mortality and were included in the analyses (Gregorio et al., 1985; Newman et al., 
1986; Nomura et al., 1991; Ewertz, 1993; Rohan et al., 1993; Jain et al., 1994; Zhang et al., 
1995; Staessen et al., 1997; Holmes et al., 1999; Saxe et al., 1999; Goodwin et al., 2003; 
Borugian et al., 2004; McEligot et al., 2006; Holmes et al., 2009; Beasley et al., 2011). 
Information extracted from each study included geographical region, sample size, age range, 
length of follow-up, dietary assessment method, timing of dietary assessment (relative to 
diagnosis), number of deaths, factors that were adjusted for in the analysis and risk estimates 
(HR, OR, RR) and factors that were adjusted for in the analysis (Table 1; Figure 1). 
Total fat intake 
The association between highest compared with lowest categories of intake of total fat (g/day) 
and breast cancer specific and all-cause death are shown in Figure 2 (A & B respectively). There 
was no evidence of an association between total fat intake and risk of breast cancer specific death 
(n=6; HR=1.14; 95% CI: 0.86, 1.52; P=0.34) or all cause death (n=4; HR=1.73; 95% CI: 0.82, 
3.66; P=0.15) for women in the highest compared with the lowest categories of total fat intake. 
There was evidence of study heterogeneity in studies that examined the association between all-
cause death and total fat intake (P<0.01; I
2
=84%). There was less evidence of heterogeneity 
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between studies that examined breast cancer specific death and total fat intake (P=0.115; 
I
2
=44%). 
Similarly, no significant difference in risk of all cause (n= 3; HR=1.06; 95% CI: 0.88, 1.28; 
P=0.52) or breast cancer specific death (n=4; HR= 1.03; 95% CI; 0.97, 1.10; P=0.26) was 
observed per linear (20 gram) increase in total fat intake. Once again, heterogeneity was most 
apparent in the analysis with studies providing estimates for all-cause death (P=0.03; I
2
=70%); 
no heterogeneity was evident for the studies providing estimates for breast cancer specific death 
(P=0.44; I
2
=0%). 
Saturated fat intake 
The association between highest compared with lowest categories of intake of saturated fat 
(g/day) and breast cancer specific death is shown in Figure 3. There was evidence of an 
increased risk of breast cancer death (n=4; HR=1.51; 95% CI: 1.09, 2.09) for the highest 
compared with the lowest category of intake of saturated fat (g/day) and these studies showed no 
evidence of heterogeneity (P=0.317, I
2
=15%). Only one study provided an estimate of risk for 
women in the highest compared to the lowest category of saturated fat intake and all-cause death 
(HR=2.4; 95% CI: 1.1, 4.9) (Zhang et al., 1995). 
No significant difference in risk of breast cancer specific death (n=4; HR=1.03; 95% CI: 0.77, 
1.38; P=0.80) was observed per linear (20 gram) increase in saturated fat intake (results not 
shown). Heterogeneity was apparent in the analysis (P<0.01; I
2
=75%). Only one study provided 
an estimate of risk of all-cause death per linear (20 gram) increase in saturated fat intake 
(HR=1.01; 95% CI: 1.08, 1.88) (Zhang et al., 1995). 
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Publication Bias 
Funnel plots revealed little evidence of asymmetry (not shown) and therefore little evidence of 
publication bias for studies examining the relationship between categories of total fat intake 
(g/day) and all cause death (Begg‟s test: P=0.355), and saturated fat intake (g/day) and breast 
cancer specific death (Begg‟s test: P=0.156). There was some evidence of publication bias the 
studies that reported an association between categories of total fat intake and breast cancer death 
(Begg‟s test: P=0.05). 
Sensitivity Analyses 
Sensitivity analyses were performed by removing studies which did not adjust for energy intake 
and by removing studies which used a dietary history/recall as opposed to a food frequency 
questionnaire, but no difference in the risk of all-cause or breast cancer death was observed for 
highest compared to the lowest intake of total fat (g/day) or saturated fat (g/day). Although not 
significant, slightly stronger associations were seen in studies investigating highest versus lowest 
intakes of total fat and breast cancer specific death which had adjusted for energy (n=3; HR: 
1.26; 95% CI: 0.84, 1.89) compared to those which did not (n=3; HR: 1.10; 95% CI: 0.72, 1.68) 
and in studies which did not use FFQs (n=2; HR: 1.59; 95% CI: 0.52, 4.91) compared to those 
which used FFQs to assess dietary intake (n=4; HR: 1.08; 95% CI: 0.78, 1.48) . Further 
sensitivity analyses involved examining the effect of the timing of dietary intake assessment. 
Again, the main results did not change markedly, but in studies which examined diet pre-
diagnosis, highest versus lowest intakes of total fat intake were associated with an increased risk 
of all-cause death (n=3; HR: 2.65; 95% CI: 1.73, 4.05). 
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Discussion 
To the best of our knowledge, this is the first systematic review and meta-analysis of 
observational studies examining dietary fat intake and breast cancer mortality. Results indicate 
that overall, a higher intake of saturated fat may increase the risk of breast cancer death. It has 
also shown that a higher total fat intake pre-diagnosis may increase the risk of all-cause death. In 
the absence of randomised controlled trials, which specifically test the efficacy of a low fat or 
low saturated fat diet in breast cancer survivors, this meta-analysis suggests that lower intakes of 
both total and saturated fat could be beneficial in terms of survival after a breast cancer 
diagnosis. 
Although two randomised controlled trials (RCTs), the WINS and the WHEL studies 
(Chlebowski et al., 2006; Pierce et al., 2007) have been conducted to examine the role of dietary 
fat on breast cancer prognosis to date, it is difficult to compare their results with the results of 
our meta-analysis. The investigators of these RCTs aimed to reduce the total fat intake of women 
in the intervention arm of the studies to 15-20% of energy intake. Women in the intervention arm 
of the WINS trial had a 24% reduction in risk of breast cancer death compared with the control 
group (Chlebowski et al., 2006). However, women in the intervention arm also had significant 
weight loss, which could account for their lower risk of death, rather than the reduction in fat 
intake per se. Women in the intervention arm were also more likely to have had a mastectomy 
than in the control arm, which could also explain the difference in breast cancer survival between 
the study groups. Although the investigators of the WHEL trial reported no effect of their low fat 
intervention on breast cancer survival (Pierce et al., 2007), it should be noted that women in the 
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intervention arm also changed several other aspects of their diet to include 5 vegetable servings, 
16 oz vegetable juice, 3 fruit servings and 30g fibre per day. Moreover, 75% of WHEL 
participants had healthy lifestyles and consumed at least 5 servings of fruit and vegetables per 
day at baseline and prior to randomisation. The prevalence of healthy eating in the WHEL study 
is higher than other breast cancer survivor populations (Caan et al., 2005; Wayne et al., 2004) 
and it is possible that this intervention would have resulted in different outcomes in a population 
with less healthy lifestyles prior to the intervention. 
There are a number of biologically plausible mechanisms whereby total or saturated fat intake 
may increase risk of breast cancer death. It has been hypothesised that fat intake promotes 
malignant mammary cell growth by increasing circulating oestrogens (Wu et al., 1999; Löf et al., 
2007). It has also been proposed that saturated fat intake may promote breast tumour growth by 
increasing low-density lipoprotein and cholesterol levels (Le Guevel, R & Pakdel, 2001), by 
promoting an inflammatory response and by reducing apoptosis as a result of altered gene 
expression (Lee et al., 2001, Willett, 1998). As publications on dietary fat and breast cancer 
mortality and survival are few, our analyses were somewhat limited by the information available, 
and we were only able to examine total and saturated fat, but not monounsaturated, 
polyunsaturated, or trans-unsaturated fat intake and breast cancer survival, as these were not 
provided by the individual studies. It is likely however that these factors could also influence 
breast cancer survival for example through formation of reactive oxygen species (Kang, 2002). 
Overall, total fat intake was not associated with breast cancer specific or all cause death in the 
present study. However, women in the highest versus lowest category of total fat intake had an 
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increased risk of all-cause death in studies which assessed diet pre-diagnosis. Although our 
results are limited by the information provided by the individual studies, they suggest the 
potential significance of the timing of dietary assessment around breast cancer diagnosis. As it 
has been widely reported that a cancer diagnosis motivates many cancer patients to adopt a 
lifestyle change (Demark-Wahnefried et al., 2005), it would be of interest to further clarify the 
nature of this association. Furthermore, it is also possible that dietary intake during childhood 
and adolescence, which may influence a woman‟s future breast cancer risk, may also impact 
upon her prognosis (Moisan, 1990). Therefore, it would also be of interest to further examine the 
association between dietary fat and mortality after breast cancer using more considered dietary 
assessment methods. 
In the present study, a higher versus lower intake of saturated fat was associated with an 
increased risk of breast cancer death, yet no linear relationships were observed. Similar results 
have been previously reported in a study by Goodwin et al. (2003), where extremes of intake of 
polyunsaturated-saturated fat ratio, cholesterol and percentage intake from fat, amongst other 
dietary components, were associated with breast cancer survival but linear associations were not 
observed. It is therefore possible, that a mid-range intake of dietary fat, perhaps through 
consumption of a balanced diet, is most beneficial in terms of survival after a breast cancer 
diagnosis. 
Of the 15 studies included in our analyses, 11 used a FFQ to assess dietary intake. The 
limitations of FFQs are well documented and include measurement error due to overestimation 
of the range of nutrient intakes and attenuation of risk estimates. Five studies included in our 
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review used diet histories/records, which are often considered more robust dietary assessment 
methods, to assess dietary fat intake. In our sensitivity analyses, we observed stronger 
associations when we removed studies which used FFQs (analysing only those which used diet 
histories), although these results were not significantly different from the overall results. 
However, the results of the individual studies, regardless of whether they used an FFQ or a diet 
history, are limited by their use of one single measurement of diet, which cannot capture changes 
in dietary intake during the follow-up period and may not be representative of a woman‟s 
habitual diet. It has also been suggested that FFQs more accurately measure food intake rather 
than nutrient intake (Hebert et al., 1998). Hebert et al (1998) reported a positive association 
between intakes of butter, margarine, lard, red meat and bacon and breast cancer recurrence 
(Hebert et al., 1998). This finding supports the association shown between saturated fat and 
breast cancer death in our meta-analysis. 
There are inherent difficulties associated with combining results from individual studies, and the 
results of our meta-analysis are subject to the strengths and limitations of each study‟s design. 
The studies differed by geographical region, age range of participants and time from diagnosis 
when the dietary assessment was made. Adjustment for confounders was also inconsistent 
between studies resulting in the potential for residual confounding; for example some studies did 
not adjust their analyses for total energy intake. However, we conducted sensitivity analyses 
excluding studies that did not report adjustment for energy intake and although the differences 
were not significant, we observed slightly stronger associations. Body Mass Index (BMI) or a 
change in weight after a breast cancer diagnosis, which has previously been shown to be 
associated with breast cancer prognosis (Conroy et al., 2011; Protani et al., 2010) could not be 
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controlled for in our analyses since adjustment across the individual studies was inconsistent. 
Additionally, it has been suggested that the influence of dietary fat on breast cancer risk and 
outcome may be dependent upon the hormone receptor status of the breast cancer (Chlebowski et 
al., 2006, Prentice et al., 2007), but it was not possible to examine this as estimates were not 
provided by the original articles 
In conclusion, our results suggest that highest versus lowest intakes of saturated fat are 
associated with breast cancer specific death, whilst highest versus lowest intakes of total fat pre-
diagnosis are associated with all-cause death. Modification of dietary intake, both prior to and at 
the time of diagnosis, to reduce total and saturated fat intake may therefore be warranted. 
Additional studies that assess dietary fat intake at the time of or after breast cancer diagnosis, 
rather than using pre-diagnostic measures as surrogates of post-diagnostic intake are required to 
develop specific dietary recommendations for breast cancer survivors. 
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Table 1. Descriptions of the studies included in the systematic review and meta-analysis of 
dietary fat and breast cancer survival. 
 
Study Location Sample 
size; 
age 
range 
(follow-
up) 
Diet 
assessment 
method 
Time of 
dietary 
assessment 
relative to 
diagnosis 
Factors 
adjusted for in 
analysis 
No. of events 
(deaths)/total 
number of 
cases 
Risk 
estimate 
(95% 
CI) 
Gregorio 
et al, 
1985
3 
 
USA 854; 46-
55 (18-
26 yrs) 
FFQ (33 
item) 
PRE; Asked 
to recall diet 
prior to 
symptom 
onset 
Stage of 
disease, age at 
diagnosis, 
treatment delay, 
relative obesity 
Information 
not available 
1.14 
(0.13, 
0.08)
3
 
Newman 
et al, 
1986
1 
 
Canada 300; 35-
74 
(Max 7 
years) 
Diet history 
(150 item);  
24-hr diet 
recall;   4-
day diet 
record 
All 
converted to 
estimates of 
daily intake 
POST; Diet 
history 
(previous 2 
months) 
24-hr diet 
recall 
(previous 24 
hrs) 
4-day diet 
record 
(previous 4 
days) 
Weight 87/300 0.99 
(0.74, 
1.23)
1
 
Nomura 
et al, 
1991
1
 
Hawaii 343; 45-
74 (7-
12 
years) 
Diet history 
(43 item) 
consumption 
during usual 
week 
POST; Usual 
consumption 
Stage of 
disease, 
menopausal 
status, obesity 
index, 
oestrogen use, 
age 
Information 
not available 
3.17 
(1.17, 
8.55)
1
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Ewertz 
1993
2 
 
Denmark 2445; 
<75 
years 
(6-7 
years) 
FFQ (21 
item)  
POST Tumour size, 
skin invasion, 
no of positive 
lymph nodes, 
grade, age, 
residence 
805/2445 0.96 
(0.77, 
1.23)
2
 
Rohan et 
al, 1993 
1,3,5,6 
 
Australia 412; 20-
74 years 
(Median 
5.5 
years) 
FFQ (179 
item) 
POST Age at 
menarche, 
Quetelet index, 
total energy 
intake  
123/451 1.40  
(0.66, 
2.96)
1 
1.00  
(0.00, 
0.00)
3 
1.65   
(0.73, 
3.75)
5 
1.65  
(0.73, 
3.75)
6
 
Jain et 
al, 
1994
5,6 
 
Canada 678; 40-
59 years 
(Mean 
7.7 
years) 
Diet history 
questionnaire 
(previous 
month) 
POST 
(previous 
month) 
Total energy, 
age at 
diagnosis, 
smoking, body 
weight.  
83/678 1.91  
(0.73, 
5.02)
5 
1.00  
(0.92, 
1.4)
6
 
Zhang et 
al, 
1995
2,4
 
USA 893; 55-
69 years 
(Max 6 
years) 
FFQ PRE; asked 
about 
habitual 
consumption 
before 
diagnosis 
occurred 
Age, extent of 
disease, 
oestrogen 
receptor status, 
progesterone 
receptor status, 
tumour size, 
smoking status, 
education, 
family history, 
total energy 
56/698 2.50 
(1.20, 
5.30)
2 
1.00 
(0.00, 
0.00)
4 
 
Staessen 
et al, 
Belgium Total 
cohort: 
11,302; 
24 hour food 
record 
POST Age, sex, 
region, energy 
intake, 
Information 
not available 
0.92 (-
0.08, 
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1997
6 
 25-74 
years 
(3-10 
years) 
smoking, 
education 
0.00)
6
 
Holmes 
et al, 
1999
5
 
 
 
USA 
 
 
1982; 
Mean 
54 years 
(4-18 
years) 
 
 
FFQ 
completed 
most closely 
to BC 
diagnosis 
POST Age, diet 
interval, year of 
diagnosis, BMI, 
OC use, 
menopausal 
status, 
postmenopausal 
hormone use, 
smoking, age at 
first birth, 
parity, no of 
metastatic 
lymph nodes, 
tumour size, 
caloric intake 
 
378/1982 1.23 
(0.89, 
1.69)
5
 
Holmes 
et al, 
2009
1,3 
 
USA         3846; 
30-55 
years 
(83 
months) 
FFQ POST 
(previous 
year) 
Dietary factors, 
physical 
activity, BMI, 
weight change, 
reproductive 
factors, 
treatment, 
smoking 
446/3846 0.88 
(0.63, 
1.25)
1 
 
Saxe et 
al, 
1999
4,6 
 
USA 149; 
Mean 
57.8 
years 
(at least 
5 years)  
FFQ PRE (asked 
about 
consumption 
during year 
prior to 
diagnosis) 
Energy intake, 
menstrual 
status, BMI, 
disease stage 
Information 
not available 
1.51 
(0.41, 
0.51)
4 
1.72 
(0.54, 
0.27)
6
 
Goodwin 
et al, 
2003
2,4 
 
Canada 477; 
<75 
years 
(Median 
FFQ PRE 
(completed 
approx. 9 
weeks post-
BMI, age, 
tumour stage, 
nodal stage, 
adjuvant 
52/477 1.08 
(0.25, 
4.73)
2 
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6.1 
years) 
diagnosis, 
reported 
preceding 12 
month 
consumption) 
hormone 
therapy, 
adjuvant 
chemotherapy, 
total energy 
 
 
0.99 (-
0.00, 
0.00)
4
 
Borugian 
et al, 
2004
1,3,5 
 
Canada 603; 19-
75 years 
(9-10 
years) 
FFQ  POST Age, total 
caloric intake, 
stage at 
diagnosis. 
112/603 1.80 
(0.90, 
4.80)
1 
1.00 
(0.00, 
0.00)
3 
2.5  
(1.2, 
5.3)
5
 
McEligot 
et al, 
2006
2
  
USA 516; 
Mean 
64.78 
years 
(Mean 
6.6 
years)  
FFQ (100 
item) 
PRE (asked 
about diet 
during year 
prior to 
diagnosis) 
Stage of 
disease, age at 
diagnosis, BMI, 
parity, HRT 
use, alcohol 
use, 
multivitamin 
use, energy 
intake 
96/516 3.12 
(1.79, 
5.44)
2
 
Beasley 
et al, 
2011
1 
 
USA 4441; 
20-79 
years 
(Mean 
5.5 
years) 
FFQ (126 
item)  
POST 
(previous 
year) 
Factors at 
diagnosis: age, 
state of 
residence, 
menopausal 
status, 
smoking, breast 
cancer stage, 
alcohol, history 
of hormone 
replacement 
therapy; 
interval 
between 
137/4441 0.92 
(0.52, 
1.60)
1
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1
Studies included in analysis for highest vs lowest categories of total fat intake and breast cancer 
specific death   
2
Studies included in analysis for highest vs lowest categories of total fat intake and all cause 
death  
3
Studies included in analysis of per 20g increase in intake of total fat and breast cancer specific death 
4
Studies included in analysis of per 20g increase in intake of total fat and all-cause death   
5
Studies included in analysis for highest vs lowest categories of saturated fat intake and breast 
cancer specific death   
6
Studies included in analysis of per 20g increase in intake of saturated fat and breast cancer 
specific death 
diagnosis and 
diet 
assessment; 
Factors at 
follow up: 
energy intake, 
breast cancer 
treatment, BMI, 
physical 
activity 
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Figure 1 Flow diagram of study selection 
 
 
 
 
 
 
 
 
 
 
 
49 remaining articles examined dietary fat 
and breast cancer survival 
82 articles identified in initial search 
33 articles which did not examine 
dietary fat and breast cancer survival 
excluded 
5 randomised controlled trials excluded 
1 ecological study excluded 
18 reviews excluded 
7 editorials/letters/supplements/                   
communications excluded 
1 article examining marine fatty acid 
intake excluded 
1 article which presented results as 
foods excluded 
1 article which did not provide 
usable estimates excluded 
15 articles included in final analyses 
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Figure 2 A: Forest plot of the highest compared with the lowest categories of total fat intake 
(g/day) and breast cancer specific death.* Nomura: Caucasians only. 
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Figure 2 B: Forest plot of the highest compared with the lowest categories of total fat intake 
(g/day) and all-cause death 
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Figure 3. : Forest plot of the highest compared with the lowest categories of saturated fat intake 
(g/day) and breast cancer specific death. 
 
